Latest News and Press Releases

GenoSafe advances CLIA pathway for transatlantic ATMP development CLIA registration enables GenoSafe to support testing of samples from U.S.-based patients enrolled in clinical trials.This milestone...

HEPHAISTOS-Pharma appoints Stephan Braun as Chief Medical Officer to lead clinical development strategy Former ImCheck Therapeutics clinical leader joins HEPHAISTOS-Pharma as the company prepares to...

Positive Phase Ia Results in MY006 Peanut Allergy Trial; Phase Ib Patient Cohort Initiated; Advancing Tree/Birch Pollen Allergy Program MY010; Funding

Mestag Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial

SERB Pharmaceuticals to acquire development and commercialisation rights to Idefirix® (imlifidase) in Europe and MENA from Hansa Biopharma for €115 million

Santa Barbara, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- The Star Room at Vista del Monte, a Front Porch senior living community in Santa Barbara, has been named the Best Practice/Innovation of the...

Encinitas, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Scripps Health today announced the upcoming opening of the Lusardi Tower, which is part of a nine-phase major expansion of the Scripps Memorial...

Washington, DC, May 18, 2026 (GLOBE NEWSWIRE) -- High-performing Chronic Condition Special Needs Plans (C-SNPs) require precise population targeting, provider alignment, and operational...

IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment.Maximum dose reached with no dose-limiting toxicities observed.TLX101-Tx is also the subject of a pivotal trial, IPAX BrIGHT,...

CAMBRIDGE, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact...